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Abstract
Tissue engineering results from the use of cells and scaffolds to reproduce structural and
spatial organization or function of a tissue. The Production of an ideal engineered tissue
depends on its  designed purpose.  For  clinical  applications,  the main concerns are
biocompatibility and the generation of a tissue able to mimic most of its original biological
functions. Moreover, the viability of an implanted tissue is associated with its stability to
support vascular networks. This chapter summarizes the theory of the self-assembly
approach for tissue engineering. Adjustments and modifications in stromal thickness and
extracellular  matrix  composition  for  various  self-assembled  tissues  are  discussed.
Methods developed to generate tissue closely mimicking the native morphology and
structure, to incorporate capillary-like networks, and to reduce production time and costs
are also reviewed. The self-assembly technique leads to the production of a stroma free
of exogenous material and can be adapted to generate fastest, inexpensive, and near-to-
native tissue bioengineering for medical and fundamental research applications.
Keywords: Tissue engineering, Self-assembly, Stroma, Epithelial cells, Endothelial
cells
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1. Introduction
The extracellular matrix (ECM) is present within all tissues and organs. It constitutes the
noncellular microenvironment around the cells that plays an important role in modulating their
behavior and functions [1]. This elaborated milieu is very dynamic and extremely adaptable [2–
4]. ECM is composed of several components that include proteoglycans, as well as collagen
proteins and noncollagenous glycoproteins. Each component has several subcategories of
molecules that influence the ECM physical and biochemical properties [5].
1.1. ECM deposition and assembly
The homeostasis of epithelial tissues depends on a dynamic interaction of the stroma compo‐
nents, such as fibroblasts, adipocytes, and nonactivated immune players [6]. In fact, fibroblasts
were reported to secrete and organize type I and type III collagens, elastin, fibronectin,
tenascin, and a repertoire of proteoglycans (hyaluronic acid (HA) and decorin), that maintains
interstitial ECM integrity [7]. The ECM is constantly remodeled to allow the healthy tissue to
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resist to a wide range of tensile pressures [8, 9]. This remodeling occurs through the synthesis
of elastin, which originates secreted tropoelastin, the precursor of elastin, that assembles into
fibers and becomes cross-linked on lysine residues by members of the lysyl oxidase (LOX)
enzymes and lysyl oxidase homologues (LOXL) molecules [10]. LOX and LOXL catalyze the
first step in the formation of collagens and elastins, a very conserved process that plays an
important role in cell growth, chemotaxis, or sprouting of new blood vessels [11, 12]. On the
one hand, coordinated secretion of matrix metalloproteinases (MMPs) by fibroblasts mediates
ECM remodeling [13]. On the other hand, the mesh networks are counterbalanced by tissue
inhibitors of metalloproteinases (TIMPs) [14] or by other enzymes such as LOX molecules and
transglutaminases that stiffen the ECM [10].
2. Cellular players and ECM production
2.1. Mesenchymal stem/stromal cells
Adult mesenchymal stem/stromal cells (MSCs) are found in all postnatal organs and tissues,
and they play important functions in tissue injury repair and general homeostasis [15]. These
cells are one of the principal adult stem cells and the most promising tool for regenerative
medicine because of their sustained proliferative capacity and their multipotent differentiation
potential [15–17].
2.1.1. Fibroblasts
Fibroblasts are nonterminally differentiated mesenchymal cells derived from the embryonic
mesoderm [18]. They are found in the connective tissue, a tissue that supports the whole body.
Fibroblasts are spread in the ECM containing fibrous proteins and gel-like substances. In fact,
fibroblasts produce the ECM proteins, such as fibrous collagen and elastin, as well as adhesive
proteins such as laminin and fibronectin. Fibroblasts are also the major source of glycosami‐
noglycans (hyaluronan and glycoproteins) [19]. Interconnecting meshworks of extracellular
protein fibers and connector proteins provide the architectural tissue structure. Moreover, this
milieu forms the connections needed for cellular migration of fibroblasts, immune cells, and
endothelial cells (ECs) during angiogenesis [19].
Most tissues are composed of a simple or multiple layers of epithelial cells that exhibit an
apical–basal polarization. The basal part is in contact with the basement membrane, whereas
the apical side is oriented toward the fluid-filled lumen [20]. Fibroblasts form a basement
membrane, composed of a layer of basal lamina and a layer of reticular lamina. This basement
membrane serves essentially as a structural scaffold that maintains the dynamics of a three-
dimensional (3D) engineered tissue. It is also critical for tissue regeneration in wound healing
and acts as a cell barrier. The basement membrane acts as a cell barrier by segregating epithelial
cells from endothelial cells (ECs), thus preventing tumor invasion or metastasis.
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2.1.2. Myofibroblasts: functions and origins
Myofibroblasts, or activated fibroblasts, are contractile, resistant to apoptosis and have an
upregulated rate of matrix deposition. They also express different cytokine and chemokine
receptors that enable fiber regulation and wound contraction at injury sites [21–24]. In this
sense, activated fibroblasts not only favor wound healing, but can also cause injuries when
their activation is uncontrolled, producing a pathological fibrotic response [25, 26]. The
precursor of myofibroblast is not precisely known, but many cells can differentiate into
myofibroblasts through different signaling pathways or gene regulation. Some of these
precursors include epithelial cells, ECs, pericytes, multipotent monocytes, and fibroblasts.
2.2. Adipose tissue–derived stem cells
Fat is an abundant and accessible source of stem cells. Adipose tissue–derived stem cells
(ASCs) include preadipocytes, and a subpopulation of stromal cells able to differentiate into
multilineages, including neuronal cells, chondrocytes, and osteoblasts [27, 28]. Moreover, these
MSCs are able to secrete cytokines and growth factors promoting regenerative processes
because they can influence cell recruitment, proliferation rates, or inhibit apoptosis [29, 30].
ASCs extracted from liposuctions can be expanded in culture and used as building blocks for
tissue engineering. Both connective and adipose tissues were engineered in vitro using ASCs
[31–33]. Both allogeneic and xenogeneic ASCs can be transplanted in patients regardless of
their immunocompatibility and without the need of immunosuppression therapy, making
them an unlimited source for regenerative medicine applications [34].
3. Tissue engineering history and techniques
As medical treatments and expanded lifespan expectancies in both males and females have
improved, the number of individuals waiting for organ transplants or blood vessel bypasses
is constantly increasing but the availability of organs does not often match the demand. To
circumvent this shortage in organ and tissue supplies, many efforts in cell culture methods
were deployed to engineer tissues that could be used as an alternative therapeutical option.
3.1. Self-assembly technique
The self-assembly technique is based on the ability of MSCs to secrete and organize their own
ECM to produce sheets. This tissue engineering method allows the production of autologous
living tissues, free of exogenous biomaterials [35–37]. The self-assembly technique has
exploited the inherent characteristics of MSCs to produce ECM. For instance, it was well
documented that ascorbic acid, a vitamin C derivate, promotes collagen protein synthesis and
deposition of sulfated glycosaminoglycans in human skin substitutes [38]. Once fibroblasts
supplemented with ascorbic acid are cultured for 21–35 days, they form sheets of matrix where
stromal cells are embedded within [35]. These sheets can be peeled from the culture dish and
superimposed. The superimposed layers are maintained for an additional week for further
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cell-matrix reorganization and layer fusion (Figure 1A). Holes can be made in the multilayer
dermal equivalent and hair follicles can be added to mimic the presence of native skin
component. An additional culture time is required before seeding keratinocytes. Thereafter,
the skin equivalent is maintained for 21 days at an air–liquid interface to induce the cornifi‐
cation of the epidermis [36, 39].
Figure 1. Schematic representation of self-assembled tissues. A) The classical self-assembly technique requires stack‐
ing of three fibroblast (Fb) cell sheets that are cultured for 4 weeks in the presence of ascorbic acid. Sheet fusion lasts 4
to 7 days. B) After 4 weeks of Fb cultures, the stroma is seeded with endothelial cells (ECs) and then a fusion set is
carried on to generate endothelialized tissues. C) Modification to the self-assembly technique consists of an initial Fb
culture for 2 weeks followed by an additional Fb reseeding. The culture is maintained for an additional 2 weeks before
using the stroma without stacking. D) Fb and EC are co-seeded in order to generate endothelialized tissues with a 3D
capillary-like network.
3.1.1. Engineered human skin substitutes
One of the great breakthroughs in medicine was achieved by engineering human skin
substitutes for grafting purposes. Self-assembled skin substitutes were generated by extracting
the patient’s own cells, thus avoiding immunological incompatibility problems upon grafting.
These skin substitutes were characterized and showed a fully differentiated epidermis,
structural and morphological resemblance to native human skin. Moreover, these in vitro
engineered tissues were able to deliver cytokines, chemokines, and growth factors at the
grafted site, improving the wound closure [36, 40–43]. Because of all these characteristics, self-
assembled human skin is clinically used for wound healing and burn treatments [44, 45]. Self-
assembled skin substitutes possess a near-to-native architecture and maintain their cell growth
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potential and matrix deposition. Therefore, these equivalents are free of exogenous material,
cytotoxicity, and have clinically reduced morbidity in burnt patients (reviewed in Refs. [46, 47].
Over the years, self-assembled skin substitutes were also produced from extracted cells of
patients having psoriasis [48]. The reconstructed tissues from psoriatic donors represent an
ideal model to study one of the most common human skin diseases. In fact, this model outlines
the excessive growth and aberrant differentiation of keratinocytes. It offers a reliable in vitro
mean to measure the efficacy of appropriate treatments, perform tests directly on human
primary cells, and avoid animal use [48–52]. Furthermore, self-assembled skin substitutes were
used to extensively characterize cellular and molecular players involved in the pathogenesis
of hypertrophic scars and scleroderma [53–55]. More recently, a skin substitute derived from
patients diagnosed with amyotrophic lateral sclerosis (ALS) was similarly generated. As one
of the early perturbations in ALS patients is skin alterations that often precede the neurological
symptoms, this human skin model is designed to better identify disease-specific biomarkers
and early diagnostic tools to monitor disease progression [56].
3.1.2. Cardiovascular tissues
The self-assembly technique was customized to engineer human blood vessel that displayed
excellent physiological and mechanical properties without the need for any exogenous scaffold
[35, 57]. Blood vessels are constituted of a functional endothelium seeded onto an internal
membrane of human skin fibroblasts. In order to mimic the shape of a blood vessel, a smooth
muscle cell (SMC) sheet is first rolled, followed by the fibroblast sheet around a cylindrical
Figure 2. Vascular self-assembled tissue. A) A sheet of smooth muscle cells (SMC) (first) and a sheet of fibroblasts
(Fb) (second) are rolled around a cylindrical support after 4 weeks of culture. The construct is allowed to fuse and ma‐
ture in a bioreactor. B) Modification to the technique shown in (A) consists of co-seeding SMCc and Fb each at an ex‐
tremity of the same sheet, which is rolled around a cylindrical support after 4 weeks of culture and then allowed to
fuse and mature in a bioreactor.
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support, and cultured until fusion (Figure 2A). Analyses of these in vitro engineered vessels
confirmed the presence of numerous ECM proteins (collagen types I, III, IV, laminin, fibro‐
nectin, and chondroitin sulfates) and a functional endothelium [35, 58, 59].
Progress in developing self-assembled valves was reported over the years [60, 61]. Valve
leaflets made of self-assembled tissue sheets can organize into a characteristic three-layer
structure featuring appropriate dynamic fluidics [60]. This tissue remains to be grafted into
living recipients in order to assess in vivo survival and behavior of the transplanted valve.
Nevertheless, this stentless bioprosthetic offers a great alternative to artificial valves for
cardiovascular surgeries [60, 61].
3.1.3. Cornea
Corneal tissue engineering was developed in an attempt to cure corneal opacity by replacing
the damaged area with a clear substitute. Proulx et al. [62] generated a self-assembled three-
layer equivalent of human cornea. These substitutes presented near-to-native stromal,
endothelial, and epithelial morphology with an intact basement membrane filled with laminin
V and collagen VII proteins. The differentiated epithelial layer had defined basal and wing
cells that expressed Na+/K+ ATPase α1 protein, keratin 3/12, and basic keratins. This human
cornea model was also used to study the pattern of MMP genes expression during corneal
wound healing [63].
3.1.4. ASCs for the production of adipose tissues and other connective tissues
Adipose cell sheets can be generated in vitro using the self-assembly technique supplemented
with ascorbic acid and adipogenic differentiation factors. These sheets share many adipocyte
features [64]. ASCs have the ability to respond to media composition and motion allowing
them to be an optimal cell type for tissue engineering. Using the self-assembly technique, fully
autologous vascular tissues were also engineered from ASCs in vitro, with an organized
structure and matrix components [65]. Other studies showed that ASCs could be used to
bioengineer near-to-native skin [31] and bladder mucosa equivalents [66] in vitro.
3.1.5. Urogenital tissues
In vitro reconstruction of a bladder substitute using the self-assembly technique was first
documented by Magnan et al. [67], where a single porcine biopsy was processed and allowed
the generation of an endothelialized bladder equivalent. Subsequently, seeding urothelial cells
on a dermal fibroblast stroma generated tubular urethral grafts for in vivo replacement. To
mimic in vivo tissue architecture, the engineered construct was placed under perfusion in a
bioreactor [68]. ECs were also added to the model [69]. The human tissue–engineered bladder
model can be used to screen common prescribed medicine. For instance, this model was used
to study ketamine, an anesthetic agent and a drug used in chronic pain management, which
is excreted in the urine. The drug application on the 3D bladder model showed that ketamine
directly damages the urothelium, especially the structure and the interconnections that
characterize the intermediate epithelial layers, by inducing apoptosis [70].
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4. Improvements of stromal thickness and mechanical properties of self-
assembled tissue
The self-assembly technique has great therapeutic potential because it uses autologous cells
that produce their own ECM, thus reducing allogeneic graft rejection. Although the self-
assembly approach is suitable for clinical applications, the time required for tissue reconstruc‐
tion and the costs are important drawbacks hindering its wider use. Hence, many strategies
to reduce tissue reconstruction time and the cost associated with cell culture were investigated.
Efforts to stimulate collagen deposition and matrix reorganization are detailed in this section.
4.1. Mechanical stimulation
Mechanical stimuli induce major biological modifications in the organization of the cells
cytoskeleton and their ECM composition [71, 72]. For instance, the mechanical stimulation of
blood flow induces the realignment of collagen fibers and strengthening of the tissue [73, 74].
At the molecular level, these changes are triggered by the activation of mechanoreceptors such
as the ones containing the Arginyl-Glycyl-Aspartic acid attachment site that bind to integrins
[75]. This mechanical stimulation often results in activation of extracellular signal–regulated
kinase, ERK, and the c-Jun N-terminal kinase, JNK, signaling pathways that will induce cellular
responses in order to adapt to new environments [75]. In some studies G-proteins seem to be
also involved in the molecular signaling [76]. In response to mechanical stimuli, cells can also
secrete growth factors such as transforming growth factor-beta (TGF-β) [77] that will exert
paracrine or autocrine functions. Furthermore, cells can secrete and/or activate latent MMPs
and other proteases [78, 79], which affect the balance between synthesis of ECM elements and
their degradation. Accordingly, fibrosis was observed in mechanically overstimulated settings
emphasizing that increased collagen deposition rates need to be controlled in order to remain
reversible [80].
4.1.1. Improved blood vessels generation
The quality of engineered vascular tissues can be improved in a bioreactor by applying the
appropriate laminar/cyclic flow. Other modification to the self-assembled blood vessel
generation, such as co-seeding fibroblasts and SMCs, each at their respective half of the same
sheet, before rolling around a cylindrical support [81] (Figure 2B) was reported. The fully
autologous vascular substitutes possess high-grade mechanical strength to sustain
engraftment and are readily available when needed without any immunosuppressive
treatments [81–83].
4.1.2. Specific culture surface can influence fiber alignment in engineered tissues
Tissue functions can be improved using microstructured surfaces that control the interactions
between cells and the ECM. With the use of a specific surface topography on an elastomeric
material, it was observed that the first cell layer followed the same patterns and orientation as
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the material. Subsequently, this orientation influenced the second cell layer to follow a
physiologically similar alignment mimicking the structure of the native tissue. Furthermore,
secreted ECM followed cell orientation in every layer, resulting in very well-structured self-
assembled sheets for cornea, vascular, and dermis. A micropatterned surface on which cells
are seeded have the capacity to generate multiple layers, in which cells and the ECM sponta‐
neously organize in patterns consistent with the original tissue [84].
4.1.3. ASCs cultures in dynamic conditions
In order to reduce culture time required for tissue production, human ASCs were used to
replace dermal fibroblasts in some self-assembled tissues. Self-assembled stromas generated
with dermal fibroblast or ASCs can be subjected to static or dynamic conditions [85], as they
can be mechanically stimulated on a 3D shaker platform. Dynamic culture conditions increased
(1.5- to 2-fold) the thickness of tissues derived from ASCs compared to static conditions.
Moreover, culture time could be reduced in dynamic conditions. Yet, mechanical properties
of these tissues were not measured.
4.2. Enzymatic reactions and chemical stimulation
Although ascorbic acid is an essential element that contributes to collagen deposition, an
increase in its concentration does not lead to enhanced collagen deposition. Ascorbic acid is
an enzymatic cofactor of prolyl- and lysyl-hydroxylase [86], and its action reaches a plateau
when these enzymes achieve their peak of activity. Independently of its role as a cofactor,
ascorbic acid is responsible for a certain level of collagen secretion in fibroblast cultures, until
it reaches its biological limits [87], albeit it can be toxic for fibroblasts if present in high dose [23].
Chemical inhibitors of MMP could also increase ECM production by restricting the extent of
protease activity. Among them, galardin was used to produce self-assembled tissues and it
significantly increased the thickness of treated tissues [54]. Currently, the cost associated with
the use of galardin is too expensive to be a promising solution.
L-arginine (L-Arg) is converted in ornithine followed by glutamine semialdehyde and finally
proline, an important amino acid that is metabolized during collagen synthesis. L-Arg
supplementation to culture media was evaluated, when the stroma was produced using the
self-assembly method. Although an increase in collagen synthesis and secretion (20% more
collagen type-I) was observed, collagen deposition remained unchanged when compared to
controls [88]. A plausible explanation would be that enzymes involved in collagen matura‐
tion were not sufficient to process the surplus of this amino acid in vitro.
4.3. Biological stimulation
Biological stimulation of ECM deposition in the field of tissue engineering is a challenge. This
complexity is due to pleiotropic roles of multiple bioactive agents and their subtle effects,
which could appear after a long period of time, for instance after tissue implantation. In
contrary to monolayer culture studies in which experiments rarely exceed days, tissue
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engineering methods can be carried out for months, especially if it involves in vivo implanta‐
tion. Many proteins, peptides, and lipids can be used to stimulate collagen synthesis and
deposition. Most of them are involved in fibrosis and need to be carefully handled to avoid
production of pathological-like tissue.
4.3.1. Polysaccharides
Beta-glucans constitute a family of carbohydrates that stimulates fibroblasts to produce
collagen [89, 90]. For instance, laminaran, a glucan from Saccharina longicruris seaweed,
increased collagen secretion when added to dermal fibroblast culture [91]. An increase in
collagen synthesis and secretion was observed in self-assembled tissues. Moreover, thicker
stroma could be obtained without significant increase in cell proliferation and alpha-smooth
muscle actin content, a hallmark of fibrosis [92]. The authors argued that the aggregation
properties of laminaran triggered a net increase of collagen secretion without inducing a
fibrotic phenotype [92, 93].
Tissue engineering often relies on glucose-rich media because glucose is the primary source
of energy that allows MSCs to produce ECM compounds. Advanced glycation end-products
(AGE) result from glucose metabolism and are found in elderly tissues or in diabetic patient
tissues [94]. Unfortunately, the glucose concentration used during the production of most self-
assembled tissues is too high. Consequently, it was reported that AGE are involved in the
process of skin aging, which has an impact on mechanical and biological parameters [95]. New
approaches to circumvent this issue are currently being developed and should generate
promising alternatives.
4.3.2. Insulin and hypoxia
In addition to mediating glucose entry in cells, insulin also plays an active role in collagen
synthesis and deposition [96]. Insulin has a long history of safety use for human therapies and
microencapsulated insulin-secreting cells in hydrogels can improve collagen fiber density in
diabetic mouse models [97]. Poly-lactic-co-glycolic acid (PLGA) alginate structure that releases
insulin in rats was also found to increase collagen deposition and maturation [98]. In a clinical
setting, wound healing is problematic for diabetic patients because their insulin metabolism
is altered. Also, their tissues are less irrigated because of microvascular network changes
caused by the loss of ECs. When capillary networks are altered, the surrounding tissues
undergo hypoxia. In such an environment, fibroblasts change to a fibrotic phenotype. Fibrosis
is induced by factors that are released by damaged ECs [99], as well as by other unknown
mechanisms [96, 100]. Insulin and hypoxia exert a synergic effect on self-assembled tissues.
They increase collagen deposition as demonstrated by tests on human and animal cell
cultures [101] (unpublished data). Nevertheless, long-term effect of hypoxia exposure (more
than 2 weeks) induced acidification of the cell culture medium and a thinning of the engi‐
neered tissues [102]. Hence, cyclic hypoxia seems a better alternative than constitutive hypoxia
because it produces thicker tissues in vitro.
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4.3.3. Adenosine
Adenosine and other derivatives have been used to enhance the rate of wound healing [103].
Their receptors were also found to be involved in fibrosis. Activation of A2B-adenosine
receptors resulted in an increase of collagen synthesis and a decrease in MMP-9 activity [104,
105]. This molecule was successfully tested to produce rabbit tissues by the self-assembly
approach [101]. Effects of adenosine on human cultures remain to be evaluated.
4.3.4. Lysophosphatidic acid
Lysophosphatidic acid (LPA) is a bioactive lipid found in blood. LPA binds to its receptors at
the surface of many cells and activates pathways leading to proliferation, migration, and
secretion of cytokines. LPA expression is upregulated in disease conditions such as in fibrosis
and cancer or cancer [106, 107]. As LPA is naturally present in human blood, it was used in
vitro and approved by regulatory agencies. LPA-cultured fibroblasts showed increased
collagen type-I and fibronectin deposition in a dose-dependent manner that could be com‐
pletely reversible. No adverse effects were noted: alpha-smooth muscle actin was not
overexpressed and cell proliferation rates remained normal [108]. Thicker stroma and
enhanced collagen deposition kinetics suggested that the production time could be reduced
by 25% when LPA was added to the cell culture medium.
5. Bioengineering substitutes that resemble native tissues
Classical self-assembly technique involves sheet stacking in order to generate a tissue with
sufficient mechanical strength. The superimposition of sheets Influences cell distribution.
Although fusion of all sheets occurs following sheet stacking, a pattern at the site of each sheet
fusion remains visible. Epithelial cell seeding has been noted to reduce sheet demarcations
after sheet stacking. Nevertheless, different layers are visible in the 3D self-assembled tissue,
Which does not correspond to native stroma architecture and weakens tissue mechanical
strength [31, 66, 85, 88]. To outwit this issue, a newly reseeding self-assembly protocol was
elaborated and allowed a more uniform distribution of cells throughout the tissue without
delineation marks [88].
5.1. Reseeding self-assembly technique
Ascorbic acid triggers collagen deposition that reaches a plateau level after 2 weeks of
fibroblast culture [88]. This time period also correlates with the thickness reached by self-
assembled tissue [85]. When fibroblasts reach confluence, the cells begin to secrete and deposit
collagen to form the ECM, a step that lasts 2 weeks before collagen synthesis rate decreases.
These observations led to the generation of engineered tissues by reseeding of cells instead of
sheet stacking (Figure 1C). The new reseeding approach is based on the fact that a second layer
of fibroblasts seeded onto the first sheet will concomitantly induce a transitory peak of MMP
activity and a boost of collagen secretion. The fibroblasts in the first sheet play a role in this
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remodeling, and after an additional 2 weeks of culture, the reseeding process results in the
generation of a stroma with the same thickness as the one obtained by classical stacking of
three sheets produced without reseeding. This dense stroma supported the development and
maturation of the epithelium [88]. The reseeding technique offers a remarkable alternative to
the classical self-assembly protocol because it is faster and it reduces costs associated with
extensive culture medium consumption as well as material [88] (Figure 3).
Figure 3. Graphical illustration of the improvements to the self-assembly technique (SS) when reseeding of cells
(RS) is applied. Reseeding allows the reduction of costs, handling time, and incubator space requirements throughout
the steps of cell culture.
5.2. Organ-specific stroma
Over the years, it has been shown that the origin of mesenchymal cells has a direct impact on
the quality of bioengineered tissues. Carrier et al. [109] showed that reconstructed human
cornea substitutes had great macroscopic and histological differences; especially in the corneal
epithelium thickness and differentiation whether dermal fibroblasts or keratocytes (corneal
fibroblasts) were used to produce the ECM. Constructs made with dermal fibroblasts were less
transparent and lacked ultraviolet absorption characteristics compared to corneal tissues
which were produced using autologous keratocytes [109]. The importance of this cross talk
was further evaluated by mass spectrometry analyses performed on human stromal and
epithelial layers of corneal substitute. Not only is the origin of mesenchymal cell important,
but a fully differentiated and stratified epithelium is required for appropriate ECM synthe‐
sis and organization. This reciprocal regulation between the ECM and epithelial components
is initiated as epithelial cells adhere to the stroma, they emit a continuous signal that medi‐
ates ECM remodeling accordingly [63].
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Modifications to the original protocol have generated near-to-native self-assembled bladder
and urethral human tissues. Many improvements include mechanical stimulation [68], the use
of autologous human stromal cells, urothelial cells, urine[110, 111], and a new proposed
reseeding technique of stromal cells [88]. In particular, the absence of an air/liquid interface
and the presence of urine allowed the new bladder mucosa model [110] to be continuously
cultured in submerged conditions. Consequently, these modifications generated a bladder
model that preserved the best urothelial cell properties and uroplakin distribution [110, 111].
5.3. Importance of blood vessels for tissue homoeostasis
Blood vessel formation can occur through two distinct mechanisms: angiogenesis and
vasculogenesis. Vasculogenesis involves the recruitment of progenitors of ECs from the bone
marrow, which leads to the formation of a vascular plexus de novo, whereas angiogenesis
occurs when pre-existing vessels form new branches or sprouts [112, 113]. Finally, inoscula‐
tion of a tissue is the anastomosis of the pre-established capillary-like network within the graft
or engineered tissue with the host’s vasculature [114].
ECs are in a stable quiescent state, however, they can become activated upon angiogenic
stimuli in engineered tissues [115]. For instance, in response to conditions, such as tissue
ischemia or chronic hypoxia, new collateral vessels can grow. Endothelium proliferation is
stimulated by growth factors such as vascular endothelial growth factor (VEGF) that induce
sprouting of new blood vessels. Additionally, proangiogenic signals increase MMP activity
that prompts ECs to break apart their basement membrane allowing sprouting [116].
5.3.1. Vascularization strategies in tissue engineering
ECs are a promising angiogenic cell source for therapeutic vasculogenesis because they have
the potential to proliferate and rearrange themselves into functional capillary-like networks.
Human umbilical vein endothelial cells (HUVEC) are an important source of ECs widely used
in vasculogenesis [117]. Advantages of this cell type use are the noninvasive cell source, the
profusion of medical wastes, and the impressive source of ECs in umbilical cords and placental
tissues. Although the therapeutic use of HUVECs is limited because of their allogeneic nature,
they remain a valuable EC source for basic and applied research needs [117].
To overcome this issue, the potential of ASCs for their differentiation into ECs was explored.
Isolated adipose stromal vascular fraction (SVF) from white human adipose tissue is rich in
adult stem cell populations, including EC progenitors. Freshly harvested SVF containing
mixed white adipose stromal cells and white adipose ECs was cultured in 3D collagen
hydrogels. Within the first week, the culture showed a formation of capillary network with
continuous lumen [118], and after 3 weeks it gave rise to a functional 3D vascularized skin
substitute that responded well to implantation in mice. This experiment demonstrates the
synergy of vascular and stromal cells in blood network formation de novo. Hence, white ASCs
Demonstrate promising results with minimal cell handling. Finally, human microvascular
endothelial cells (HMVEC), which originate from small superficial capillaries, also represent
a promising avenue for tissue endothelialization. These cells have been incorporated in in vitro
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models using the self-assembly method and formed vascular networks with lumen [115].
HMVECs are an easily accessible source because they can be derived from a skin biopsy or
any other tissue. The use of HMVECs could be particularly suitable for therapeutic applica‐
tion because it is best adapted for organ specific reconstructs.
5.3.1.1. Vascularization of self-assembled tissues
The co-culture of dermal fibroblasts and keratinocytes with HUVEC on a chitosan/collagen
sponge showed the establishment of a capillary-like network similar to the microvasculature
found in vivo [119]. Prevascularization of tissues prior to implantation has yield impressive
improvements in regenerative medicine. In 2005, human endothelialized reconstructed skin
models revealed an important reduction in the delay of functional vascularization after
implantation in mice. Early signs of vascularization were observed in the endothelialized
human skin grafts within 4 days following tissue implantation, as opposed to 14 days in the
nonendothelialized reconstructed skin. Mouse blood vessels were only detected after 14 days
in both models demonstrating that neovascularization is a latter process. The uniform
distribution of ECs across the reconstruct ensures adequate perfusion of the entire graft. The
colocalization of human and host mouse ECs inside a human capillary within the graft suggests
the formation of chimeric microvessels and confirms inosculation between both microvascu‐
lar networks [114] (later confirmed in Gibot et al. [120] generated self-assembled tissue).
The progress of endothelialized tissue–engineered dermal substitutes lead to the introduc‐
tion of a new in vitro model of capillary-like network formation in self-assembled skin
substitutes without the use of an exogenous scaffold. In this approach, stromal sheets, formed
by culturing dermal fibroblast during 4 weeks, were seeded with ECs. To generate the 3D skin,
two endothelialized stromal sheets were stacked and allowed to fuse [121] (Figure 1B).
Although a capillary network was observed, the fact that ECs were seeded in a single plane
orientation, on top of the stromal sheets, resulted in a vascularized skin model with mainly a
2D vascular network rather than a 3D network. In order to provide the reconstructed skin with
the optimal 3D capillary network, ECs were co-seeded with fibroblasts (Figure 1D). Incorpo‐
ration of ECs in the reconstructed model using the reseeding technique produced a capillary-
like network with increased tissue elasticity and mechanical strength [88]. Moreover, because
fibroblasts were seeded at high density, ECM was readily generated and allowed the dermal
stroma to be rapidly embedded with ECs [88].This vascularized stroma had pericyte-like cells
that expressed the neuron-glial 2 (NG2) marker, which characterizes the surrounding of
capillary-like structures.
6. Conclusions
The self-assembly approach is used to generate several tissues for fundamental and clinical
research applications. Over the years, adjustments to the stroma elaboration protocols and
especially the ECM generation were proposed to improve the quality of the bioengineered
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substitutes. As one of the main objectives is to reduce the production time and costs, mechan‐
ical, biological, and chemical modifications were also introduced. Organ-specific ECM was
associated with a better epithelial differentiation and an overall tissue architecture that closely
mimics native tissues. To improve clinical applications, endothelialized tissues were generat‐
ed and grafted with better survival and functions compared to nonvascularized substitutes.
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